NCT03652428 2026-03-02
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
University of Maryland, Baltimore
Phase 1/2 Recruiting
Clinical Trials
14 trialsNCT07429643 2026-02-24
Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.
Assiut University
Phase 2/3 Not yet recruiting
NCT07407231 2026-02-17
Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT04276857 2025-05-13
SMART
University of Saskatchewan
Phase NA Recruiting
NCT06669078 2024-11-01
NALIRIFOX
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Not yet recruiting
NCT06429904 2024-05-28
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital
Phase 2 Active not recruiting
NCT05988372 2023-11-01
Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06009029 2023-08-24
SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)
Peking University Third Hospital
Phase 2 Not yet recruiting
NCT03648632 2022-04-20
SBRT-PC-01
Odense University Hospital
Phase NA Completed
NCT04723030 2021-01-25
The Transformation of Locally Advanced Pancreatic Cancer.
Peking University
Phase 2 Unknown
NCT03885219 2020-03-10
Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02898649 2019-02-15
Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Yonsei University
Phase NA Unknown
NCT01795274 2018-05-17
PHOENIX-01
University Hospital Heidelberg
Phase NA Withdrawn
NCT01063192 2010-02-05
A Study of Locally Advanced Pancreatic Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown